Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹823Cr
Plastics - Plastic & Plastic Products
Rev Gr TTM
Revenue Growth TTM
-8.73%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ARROWGREEN
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 972.2 | 265.2 | 65.8 | -19.8 | 5.2 | 50.7 | 122.7 | 121.2 | 13.2 | -37.1 | -5.8 | 1.7 |
| 30 | 29 | 20 | 18 | 35 | 38 | 39 | 37 | 41 | 27 | 40 | 37 |
Operating Profit Operating ProfitCr |
| 38.6 | 32.8 | 30.9 | 29.3 | 30.9 | 42.4 | 40.6 | 32.5 | 28.0 | 34.3 | 34.0 | 34.3 |
Other Income Other IncomeCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 18 | 13 | 8 | 6 | 14 | 27 | 26 | 18 | 16 | 14 | 21 | 19 |
| 5 | 4 | 2 | 1 | 4 | 7 | 7 | 5 | 4 | 3 | 5 | 6 |
|
Growth YoY PAT Growth YoY% | 396.5 | 305.3 | 1,305.6 | 34.4 | -21.7 | 116.3 | 267.8 | 162.9 | 13.6 | -45.8 | -15.4 | 3.6 |
| 26.6 | 21.3 | 17.4 | 19.6 | 19.8 | 30.5 | 28.7 | 23.3 | 19.9 | 26.3 | 25.8 | 23.7 |
| 8.9 | 6.2 | 3.4 | 3.3 | 6.7 | 13.4 | 12.4 | 8.5 | 7.6 | 7.2 | 10.4 | 8.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 36.9 | 4.7 | 3.5 | -34.3 | -0.8 | -35.8 | 137.8 | -35.7 | 223.1 | 36.5 | 63.9 | -11.2 |
| 19 | 14 | 16 | 29 | 49 | 30 | 44 | 41 | 85 | 102 | 155 | 146 |
Operating Profit Operating ProfitCr |
| 60.5 | 73.3 | 68.9 | 15.5 | -43.6 | -35.4 | 15.9 | -21.8 | 21.6 | 31.2 | 36.3 | 32.5 |
Other Income Other IncomeCr | 1 | 5 | 5 | 2 | 2 | 1 | 3 | 2 | 2 | 3 | 5 | 8 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 2 | 4 | 4 | 4 | 5 | 5 | 7 | 8 | 7 | 8 |
| 30 | 41 | 39 | 3 | -17 | -10 | 6 | -11 | 18 | 41 | 86 | 70 |
| 7 | 10 | 5 | 3 | 0 | 0 | -1 | -2 | 6 | 11 | 23 | 19 |
|
| 44.7 | 36.3 | 10.9 | -99.5 | -9,934.6 | 39.4 | 166.8 | -235.7 | 232.4 | 139.2 | 114.8 | -18.5 |
| 47.2 | 61.5 | 65.8 | 0.5 | -49.2 | -46.4 | 13.0 | -27.5 | 11.3 | 19.8 | 25.9 | 23.8 |
| 17.7 | 24.1 | 27.1 | 0.2 | -13.3 | -8.4 | 4.5 | -6.6 | 8.5 | 19.6 | 41.8 | 34.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 12 | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 15 | 15 | 15 | 15 |
| 35 | 58 | 86 | 86 | 66 | 62 | 70 | 61 | 83 | 112 | 173 | 197 |
Current Liabilities Current LiabilitiesCr | 12 | 15 | 5 | 5 | 6 | 9 | 8 | 8 | 17 | 14 | 15 | 17 |
Non Current Liabilities Non Current LiabilitiesCr | 1 | 0 | 1 | 1 | 1 | 5 | 4 | 4 | 4 | 3 | 4 | 6 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 30 | 50 | 57 | 46 | 36 | 31 | 42 | 39 | 77 | 84 | 153 | 185 |
Non Current Assets Non Current AssetsCr | 30 | 35 | 48 | 60 | 51 | 61 | 57 | 50 | 45 | 62 | 56 | 51 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 26 | 27 | 17 | 5 | -16 | 3 | 1 | 2 | 3 | 18 | 68 |
Investing Cash Flow Investing Cash FlowCr | -11 | -6 | -12 | -13 | 8 | -24 | 2 | -2 | -14 | -13 | -55 |
Financing Cash Flow Financing Cash FlowCr | -4 | -7 | -2 | -6 | -3 | 12 | -2 | -2 | 8 | -4 | -4 |
|
Free Cash Flow Free Cash FlowCr | 22 | 21 | 4 | 2 | -23 | -15 | -4 | -6 | -1 | 7 | 61 |
| 114.8 | 87.5 | 48.2 | 2,927.1 | 97.5 | -33.5 | 13.8 | -25.8 | 24.3 | 60.8 | 107.2 |
CFO To EBITDA CFO To EBITDA% | 89.7 | 73.3 | 46.1 | 93.8 | 109.9 | -43.9 | 11.3 | -32.6 | 12.7 | 38.5 | 76.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 449 | 648 | 492 | 379 | 94 | 47 | 93 | 147 | 386 | 577 | 787 |
Price To Earnings Price To Earnings | 20.6 | 21.5 | 14.4 | 1,405.0 | 0.0 | 0.0 | 14.6 | 0.0 | 31.4 | 19.6 | 12.5 |
Price To Sales Price To Sales | 9.2 | 12.8 | 9.3 | 11.0 | 2.7 | 2.1 | 1.8 | 4.3 | 3.5 | 3.9 | 3.2 |
Price To Book Price To Book | 9.6 | 9.3 | 5.0 | 3.9 | 1.2 | 0.6 | 1.1 | 2.0 | 3.9 | 4.5 | 4.2 |
| 14.4 | 16.3 | 12.4 | 65.4 | -5.0 | -4.2 | 9.4 | -17.9 | 15.3 | 12.0 | 8.4 |
Profitability Ratios Profitability Ratios |
| 92.7 | 95.6 | 94.0 | 76.2 | 25.0 | 44.3 | 49.0 | 42.5 | 50.1 | 60.5 | 54.0 |
| 60.5 | 73.3 | 68.9 | 15.5 | -43.6 | -35.4 | 15.9 | -21.8 | 21.6 | 31.2 | 36.3 |
| 47.2 | 61.5 | 65.8 | 0.5 | -49.2 | -46.4 | 13.0 | -27.5 | 11.3 | 19.8 | 25.9 |
| 63.2 | 58.9 | 40.5 | 3.3 | -21.9 | -12.4 | 7.1 | -13.0 | 18.9 | 32.1 | 45.6 |
| 49.1 | 45.0 | 35.6 | 0.2 | -21.7 | -13.4 | 8.1 | -12.4 | 12.5 | 23.1 | 33.5 |
| 38.1 | 36.5 | 32.8 | 0.2 | -19.5 | -11.2 | 6.9 | -10.4 | 10.1 | 20.2 | 30.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
#### **Overview**
Arrow Greentech Limited (AGTL), established in **1992**, is India’s largest manufacturer of **water-soluble films** and a globally recognized innovator in **eco-friendly materials and high-security technologies**. Headquartered in Mumbai with a core manufacturing facility in **Ankleshwar, Gujarat**, AGTL operates across two primary business segments:
- **Green Products** (eco-friendly, biodegradable, and water-soluble materials)
- **Hi-Tech Products** (anti-counterfeit security solutions and intellectual property-based technologies)
The company has a strong global footprint through subsidiaries in the **UK, Netherlands, and other international markets**, serving clients across Europe, the Americas, Asia, and Africa.
---
#### **Core Business Segments**
##### **1. Green Products Segment**
AGTL’s Green Products segment focuses on sustainable, biodegradable alternatives to single-use plastics, positioning the company at the forefront of the global green revolution.
- **Watersol®**:
- Flagship brand of **polyvinyl alcohol (PVA) water-soluble films**.
- Dissolves completely in water, leaving no residue.
- Used in agrochemicals, home care, construction chemicals, laundry bags, disinfectant pouches, and hygiene products.
- Agrochemical and home care sectors represent **60–70% of global demand**.
- **BioPlast® Division**:
- Develops **100% bio-compostable films** compliant with **EN 13432 and ISO 17088** standards.
- Made from renewable materials like **potato starch and polylactic acid (PLA)**.
- Applications include garbage bags, food packaging, disposable tableware, and industrial containers.
- Technology licensed from **Biotec, Germany**.
- **KlenzPro**:
- Offers **concentrated hygiene products in water-soluble capsules**, eliminating plastic waste.
- **Sustainability & Growth Prospects**:
- The **global PVA films market** was valued at ~$550 million in 2024, projected to grow at **5–6% CAGR through 2030**.
- Driven by rising environmental regulations and consumer demand for sustainable packaging.
- AGTL is a pioneer in **eco-industrial solutions**, aligning with **Atma Nirbhar Bharat and Make in India** initiatives.
##### **2. Hi-Tech & Security Products**
AGTL is a leader in **anti-counterfeit technologies**, serving the currency, pharmaceutical, luxury goods, and government documentation sectors.
- **Key Offerings**:
- **Security Threads & Fibers**: For integration into **banknotes, passports, tax stamps, and ID cards**.
- **Dual-Color Shift Security Film**: Patented US and Indian technology (US Patent No. 12,194,771 granted Jan 2025) that changes color when viewed from different angles—ideal for high-security documents.
- **Security Laminates**: Multi-layered, machine-readable, track-and-trace enabled films for **Aadhaar, voter IDs, and pharmaceutical packaging**.
- **Self-Destructive Security Packaging**: Prevents tampering and counterfeiting.
- **Level 2 Brand Protection**: Applied to high-value consumer goods (cosmetics, perfumes, pharma).
- **Manufacturing Capabilities**:
- Advanced processes including **metalizing, holography, nano-printing, and functional coatings**.
- Contractually confidential clients; considered a trusted indigenous supplier in a niche global market.
---
#### **Pharmaceutical Innovation via Subsidiary: Avery Pharmaceuticals Pvt. Ltd.**
AGTL owns **99.65% of Avery Pharmaceuticals**, a WHO-GMP, FSSAI, HALAL, and ISO 9001/22000 certified subsidiary manufacturing **Mouth Dissolving Strips (MDS)** and **Transdermal Patches**.
- **Arrow RX / MDS (Mouth Dissolving Strips)**:
- Commercialized under **Arrow RX**, an innovative **Novel Drug Delivery System (NDDS)**.
- Patented **"Actives Embedded Water-Soluble Film"** technology enables:
- Rapid onset of action (via **lingual, sublingual, or buccal absorption**).
- Enhanced bioavailability.
- No need for water—ideal for **pediatric, geriatric, psychiatric, dysphagic, and veterinary patients**.
- Regulatory approvals for **~50 products**, including **Sildenafil, Ondansetron, Amlodipine, and vitamin/mineral formulations**.
- FSSAI approvals for nutraceuticals and RX approvals for pharma products.
- **Operations**:
- Manufacturing plant in **Sanand, Gujarat**.
- **Commercial production began August 2022**.
- Equipped with German-engineered machinery for precision film casting.
- Full in-house R&D, QC labs, and automated production lines.
- **CDMO (Contract Development & Manufacturing Organization) Services**:
- Provides end-to-end services from **formulation development to commercial-scale manufacturing**.
- Signed long-term export contract with a **major MNC**, with repeat orders and pipeline expansion.
- Engaged in **54 CDMO projects**, including for markets such as **Brazil, Russia, Vietnam, and Yemen**.
- Active pipeline of **high-dose MDS (over 100mg)** and **combination products**.
- **Other Products**:
- **RX Matrix**: A patented system for **collection, storage, and disposal of biological samples**.
- **Transdermal Patches**: For sustained, controlled drug delivery—under development and commercial partnerships.
---
#### **Intellectual Property & Innovation**
AGTL maintains a **robust IP strategy** central to its competitive advantage.
- **Patents**:
- **23–32 granted patents globally** (number varies by report date; most recent consensus indicates **23 in force**, but earlier reports cite up to 34).
- Jurisdictions: **India, USA, UK, Europe, Russia, South Africa, Eurasia**.
- **Key Patented Technologies**:
- Cold water-soluble films.
- Actives-embedded MDS.
- Dual-color shift security film.
- Self-adhesive liner-less labels (eliminates silicone liners).
- Bio-compostable multi-layer composites (Indian Patent No. 497320).
- Medicated wound care bands (Indian Patent No. 537781).
- Water-soluble cleaning sponges and wall papers.
- **Pending Applications**:
- **15+ Indian and 4–13 foreign patent applications** under review.
- Filed via **PCT for international protection**.
- **IP Commercialization**:
- Revenue generated through **out-licensing, cross-licensing, and infringement settlements**.
- **Active litigation** against **Nu-Therapeutics and Shilpa Pharmaceuticals** for patent infringement.
- Dedicated **IP Cells in India, UK, and Netherlands**.
- **R&D Infrastructure**:
- State-of-the-art **R&D lab and IP center in Mumbai**.
- Collaborations with **academic institutions, inventors, and scientific communities**.
- Focus on **green tech, security, healthcare, and biocompostable materials**.
---
#### **Global Operations & Subsidiaries**
AGTL operates internationally with strategic subsidiaries:
| Subsidiary | Ownership | Location | Focus |
|----------|---------|--------|-------|
| **Avery Pharmaceuticals Pvt. Ltd.** | 99.65% | India | MDS, CDMO, Transdermal Patches |
| **Advance IP Technologies Ltd.** | 95% | UK | IP monetization, out-licensing |
| **Advance Secure Products B.V.** | 100% | Netherlands | Security product trade, EU market access |
| **Arrow UK** | 100% | UK | Patent trading, film export |
| **LQ Arrow Security Products Pvt. Ltd.** | 51% | India | Security systems and brand protection |
| **Arrow Secure Technology Pvt. Ltd.** | 100% | India | High-tech security R&D and manufacturing |
---
#### **Financial Highlights (as of Nov 2025)**
- **Green Products Segment**: ₹123 million revenue — demonstrates growing market traction for sustainable solutions.
- **Hi-Tech Segment**: ₹488 million revenue — driven by rising global demand for anti-counterfeit and authentication technologies.
- **Export Growth**: Increasing exports to **Brazil, South America, Africa, and EU/EEA regions**, with negligible USA exports currently.
- **Revenue Diversification**: Strong growth in **MDS, security products, and water-soluble capsules**.
---
#### **Leadership & Recognition**
- **Shilpan P. Patel** (Chairman & MD):
- Invented India’s first water-soluble film in **1990** through indigenous R&D.
- Holds multiple patents; awarded **India Star Award (2000)** and **National IP Award for Patents & Commercialization**.
- **Neil Patel** (Joint Managing Director): Oversees operations and governance.
- **Prashant Mehta** (Independent Director): Legal and corporate governance expert.
- **Awards & Recognition**:
- **National IP Awards (2019, 2021)** from CII.
- Member of **CII-DIPPIT Select Committee on IP**, supporting national innovation policy.